YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Prevalence of Hdv-Rna in Hbv-Dna Positive Patients

dc.authorid Parlak, Mehmet/0000-0001-6030-2244
dc.authorwosid Berktaş, Mustafa/Abd-1302-2021
dc.authorwosid Parlak, Mehmet/Kyp-1879-2024
dc.contributor.author Berktas, Mustafa
dc.contributor.author Parlak, Mehmet
dc.contributor.author Cikman, Aytekin
dc.contributor.author Yuce, Metin
dc.contributor.author Yaman, Gorkem
dc.date.accessioned 2025-05-10T16:46:25Z
dc.date.available 2025-05-10T16:46:25Z
dc.date.issued 2012
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Berktas, Mustafa; Yuce, Metin] Yuzuncu Yil Univ, Tip Fak, Tibbi Mikrobiyol Anabilim Dali, Van, Turkey; [Parlak, Mehmet] Van Bolge Egitim & Arastirma Hastanesi, Mikrobiyol Labaratuvari, Van, Turkey; [Cikman, Aytekin] Mengucek Gazi Egitim Arastirma Hastanesi, Mikrobiyol Labaratuvari, Erzincan, Turkey; [Yaman, Gorkem] Duzen Labrovatuvarlar Grubu Mikrobiyol & Tuberkul, Istanbul, Turkey en_US
dc.description Parlak, Mehmet/0000-0001-6030-2244 en_US
dc.description.abstract Objective: Hepatitis D virus (HDV) requires Hepatitis B virus(HBV) for replication and may cause to severe acute and chronic hepatitis. HDV is more frequently detected in our region In this study, HDV-RNA frequency was investigated in HBVDNA-positive acute hepatitis B, chronic hepatitis B and HBsAg carriers. Materials and Methods: Results of 145 serum samples were examined for HDVRNA that was detected as HBV-DNA positive in our laboratory from September 2009 to June 2010. After isolation in serum samples using magnetic particle isolation technology (Easy One), the HBV-DNA (HBV Rotor Gene PCR Kit, Qiagen((R)), Hilden) and HDV-RNA (Primer Design, UK) were examined. Results: From a total of 145 patients with HBV-DNA positive serum samples, HDVRNA positivity was found in 15 (10.3%). Conclusion: Ratio that was obtained as 10.3% in this study is compatible with the data obtained from previously studies. Considering the presence of HBV DNA negative, delta IgG positive and HDV RNA negative cases with chronic Hepatitis D, it should be addressed that the given rate would further rise. Routine HDV screening in patients presenting with findings of acute or chronic liver diseases, implementation of appropriate isolation precautions for HBV and community-wide vaccination against HBV are crucial to combat with HDV infection. en_US
dc.description.woscitationindex Emerging Sources Citation Index
dc.identifier.doi 10.4274/Vhd.18.09
dc.identifier.issn 1307-9441
dc.identifier.issn 2147-2939
dc.identifier.issue 1 en_US
dc.identifier.scopusquality N/A
dc.identifier.uri https://doi.org/10.4274/Vhd.18.09
dc.identifier.uri https://hdl.handle.net/20.500.14720/1143
dc.identifier.volume 18 en_US
dc.identifier.wos WOS:000217191600009
dc.identifier.wosquality N/A
dc.language.iso tr en_US
dc.publisher Galenos Yayincilik en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Hbv-Dna en_US
dc.subject Hdv-Rna en_US
dc.subject Pcr en_US
dc.subject Serum en_US
dc.title Prevalence of Hdv-Rna in Hbv-Dna Positive Patients en_US
dc.type Article en_US

Files